Real-world multicenter study of rezvilutamide plus androgen deprivation therapy in Chinese patients with high-volume metastatic hormone-sensitive prostate cancer.

Front Oncol · 2025 · PMC12520957 · PMID 41103956

Europe PMC DOI

hedged sentences

0.0630

closest p · 1.3× alpha

0.0630

boldest claim

The sentences

showed a trendP=0.063so close (0.05 < p ≤ 0.1)

Multivariable analysis further indicated that baseline PSA showed a trend toward being an independent predictor for achieving PSA ≤0.2 ng/mL (P=0.063).

also in 53,322 other papers

did not reach statistical significanceno p-value reported

Other traditional clinical factors such as age, ECOG score, Gleason score, bone metastasis count, and presence of visceral metastasis did not reach statistical significance after multivariate adjustment.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.